HRP20160399T1 - Sulfonamidi, namijenjeni sprječavanju dijabetesa - Google Patents
Sulfonamidi, namijenjeni sprječavanju dijabetesa Download PDFInfo
- Publication number
- HRP20160399T1 HRP20160399T1 HRP20160399TT HRP20160399T HRP20160399T1 HR P20160399 T1 HRP20160399 T1 HR P20160399T1 HR P20160399T T HRP20160399T T HR P20160399TT HR P20160399 T HRP20160399 T HR P20160399T HR P20160399 T1 HRP20160399 T1 HR P20160399T1
- Authority
- HR
- Croatia
- Prior art keywords
- diabetes
- prevention
- compound
- sulfonamides
- trifluoromethanesulfonyloxy
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims 4
- 230000002265 prevention Effects 0.000 title claims 2
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- -1 4-isobutylphenyl Chemical group 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (4)
1. Spoj formule I, ili njegova farmaceutski prihvatljiva sol:
[image]
,
gdje se R bira između nerazgranatog ili razgranatog 4-(C1-C6)alkila, 4-trifluormetansulfoniloksi i 3-benzoila i R1 je (C1-C6)alkil, naznačen time što je namijenjen upotrebi u sprječavanju dijabetesa ili u odgađanju početka i napredovanja dijabetesa.
2. Spoj namijenjen upotrebi u skladu s patentnim zahtjevom 1, naznačen time što je dijabetes dijabetes tip 1.
3. Spoj namijenjen upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 ili 2, naznačen time što se bira između R-(–)-N-2-[(4-izobutilfenil)propionil]metansulfonamida i R-(–)-2-[(4′-trifluormetansulfoniloksi)fenil]propionilmetansulfonamida.
4. Spoj namijenjen upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 3, naznačen time što se navedenA sol bira između soli s lizinom i natrijem.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09172365A EP2308485A1 (en) | 2009-10-06 | 2009-10-06 | Sulfonamides for the prevention of diabetes |
| PCT/EP2010/064920 WO2011042465A1 (en) | 2009-10-06 | 2010-10-06 | Sulfonamides for the prevention of diabetes |
| EP10768898.8A EP2485724B1 (en) | 2009-10-06 | 2010-10-06 | Sulfonamides for the prevention of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20160399T1 true HRP20160399T1 (hr) | 2016-05-20 |
Family
ID=41716341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20160399TT HRP20160399T1 (hr) | 2009-10-06 | 2016-04-18 | Sulfonamidi, namijenjeni sprječavanju dijabetesa |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US8846755B2 (hr) |
| EP (2) | EP2308485A1 (hr) |
| JP (1) | JP5745526B2 (hr) |
| KR (1) | KR101737656B1 (hr) |
| CN (1) | CN102639128B (hr) |
| AU (1) | AU2010305384B2 (hr) |
| BR (1) | BR112012007989B1 (hr) |
| CA (1) | CA2776021C (hr) |
| CY (1) | CY1117599T1 (hr) |
| DK (1) | DK2485724T3 (hr) |
| EA (1) | EA021788B1 (hr) |
| ES (1) | ES2570463T3 (hr) |
| HK (1) | HK1174557A1 (hr) |
| HR (1) | HRP20160399T1 (hr) |
| HU (1) | HUE028132T2 (hr) |
| IL (1) | IL219038A (hr) |
| ME (1) | ME02385B (hr) |
| MX (1) | MX2012004087A (hr) |
| NZ (1) | NZ599171A (hr) |
| PL (1) | PL2485724T3 (hr) |
| RS (1) | RS54693B1 (hr) |
| SI (1) | SI2485724T1 (hr) |
| SM (1) | SMT201600126B (hr) |
| WO (1) | WO2011042465A1 (hr) |
| ZA (1) | ZA201202462B (hr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9844528B2 (en) * | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
| EP3281937A1 (en) * | 2016-08-09 | 2018-02-14 | Dompé farmaceutici S.p.A. | Sulfonamides as gpr40- and gpr120-agonists |
| CA3037071A1 (en) * | 2016-10-03 | 2018-04-12 | The Children's Medical Center Corporation | Prevention and treatment of diabetic nephropathy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| ITMI20010206A1 (it) | 2001-02-02 | 2002-08-02 | Dompe Spa | Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz |
| US20040242498A1 (en) * | 2003-02-27 | 2004-12-02 | Collins Tassie L. | CXCR3 antagonists |
| RS51109B (sr) | 2004-03-23 | 2010-10-31 | Dompe S.P.A. | Derivati 2-fenilpropionske kiseline i farmaceutske smeše koje ih sadrže |
| ATE347883T1 (de) | 2004-03-25 | 2007-01-15 | Dompe Pha R Ma Spa Res & Mfg | Verwendung von n-(2-aryl-propionyl)-sulfonamiden zur behandlung von rückenmarkverletzungen |
| CN102088993A (zh) * | 2008-03-20 | 2011-06-08 | 卡罗勒斯治疗公司 | 炎症的治疗方法 |
| EP2308484A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
-
2009
- 2009-10-06 EP EP09172365A patent/EP2308485A1/en not_active Withdrawn
-
2010
- 2010-10-06 HU HUE10768898A patent/HUE028132T2/en unknown
- 2010-10-06 SI SI201031165T patent/SI2485724T1/sl unknown
- 2010-10-06 KR KR1020127010733A patent/KR101737656B1/ko not_active Application Discontinuation
- 2010-10-06 JP JP2012532578A patent/JP5745526B2/ja active Active
- 2010-10-06 EP EP10768898.8A patent/EP2485724B1/en active Active
- 2010-10-06 RS RS20160230A patent/RS54693B1/en unknown
- 2010-10-06 DK DK10768898.8T patent/DK2485724T3/en active
- 2010-10-06 US US13/500,522 patent/US8846755B2/en active Active
- 2010-10-06 ES ES10768898T patent/ES2570463T3/es active Active
- 2010-10-06 AU AU2010305384A patent/AU2010305384B2/en active Active
- 2010-10-06 PL PL10768898T patent/PL2485724T3/pl unknown
- 2010-10-06 EA EA201270512A patent/EA021788B1/ru unknown
- 2010-10-06 NZ NZ599171A patent/NZ599171A/en unknown
- 2010-10-06 ME MEP-2016-71A patent/ME02385B/me unknown
- 2010-10-06 MX MX2012004087A patent/MX2012004087A/es active IP Right Grant
- 2010-10-06 BR BR112012007989A patent/BR112012007989B1/pt active IP Right Grant
- 2010-10-06 WO PCT/EP2010/064920 patent/WO2011042465A1/en active Application Filing
- 2010-10-06 CA CA2776021A patent/CA2776021C/en active Active
- 2010-10-06 CN CN201080044851.6A patent/CN102639128B/zh active Active
-
2012
- 2012-04-04 ZA ZA2012/02462A patent/ZA201202462B/en unknown
- 2012-04-04 IL IL219038A patent/IL219038A/en active IP Right Grant
-
2013
- 2013-02-14 HK HK13101857.5A patent/HK1174557A1/xx unknown
-
2014
- 2014-09-26 US US14/497,637 patent/US9556115B2/en active Active
-
2016
- 2016-04-18 HR HRP20160399TT patent/HRP20160399T1/hr unknown
- 2016-05-03 SM SM201600126T patent/SMT201600126B/it unknown
- 2016-05-06 CY CY20161100375T patent/CY1117599T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20160399T1 (hr) | Sulfonamidi, namijenjeni sprječavanju dijabetesa | |
| HRP20202017T1 (hr) | Sintetski međuprodukt koristan u dobivanju triazolopiridina inhibitora c-met | |
| HRP20171058T1 (hr) | Derivati dipeptida lizinske glutaminske kiseline | |
| HRP20171028T1 (hr) | Indolski i indazolski spojevi koji aktiviraju ampk | |
| HRP20180528T1 (hr) | Derivati naftiridina, korisni kao antagonisti alfa-v-beta-6 integrina | |
| HRP20191186T1 (hr) | Derivati benzimidazola kao inhibitori bromodomene | |
| BR112015006537A2 (pt) | dispersão sólida, formulação farmacêutica, cápsula farmacêutica, e, tablete farmacêutico | |
| ZA201009079B (en) | "sulfonamide compounds or salts thereof" | |
| AR057894A1 (es) | Derivados de tiofeno | |
| RS54526B1 (en) | USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS | |
| WO2007031933A3 (en) | Stable pharmaceutical composition comprising a pyrimidine-sulfamide | |
| EA200701745A1 (ru) | Циклопропанкарбоксамидные производные | |
| RS53142B (en) | UNITS THAT HAVE ANTAGONISTIC ACTIVITY ON CRTH2 | |
| RS50574B (sr) | (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid 4-hidroksi-4-metil-piperidin-1-karboksilne kiseline | |
| PH12014502210A1 (en) | Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one | |
| EA200971069A1 (ru) | Метаболиты производных (тио)карбомоилциклогексана | |
| UA109421C2 (uk) | Фармацевтична композиція, яка містить ліганди сигма-рецептора | |
| RS54485B1 (en) | C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS | |
| CA2657524A1 (en) | Low-melting biocidal formulation | |
| WO2012044531A8 (en) | Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals | |
| RU2007134564A (ru) | Ингибирующие вич производные 2-(4-цианофениламино)-пиримидин-оксида | |
| RU2017102513A (ru) | Соль гетероциклического соединения, замещенного галогеном | |
| MX2009003169A (es) | Derivados de sulfonamida. | |
| RS52381B (en) | 2-METHYL-1- (PHENYLSULPHONYL) -4- (PIPERAZIN-1-IL) -1H-BENZIMIDAZOLE KAO 5-HYDROXYTRIPAMINE-6 LIGAND | |
| JP2013506703A5 (hr) |